The North America Aptamers Market would witness market growth of 17.4% CAGR during the forecast period (2021-2027).
Aptamers have been investigated as a bio-material in a variety of studies involving its usage as a diagnostic and therapeutic tool, as well as a bio-sensing probe, and in the creation of new medications, drug delivery systems, and other applications. Attempts have been made to find aptamers that are specific to targets involved in diseases like cancer and viral infection. Aptamers have mostly been researched for use as diagnostic or therapeutic tools.
Aptamers are oligonucleotides that bind to specific targets such as proteins, peptides, carbohydrates, tiny compounds, poisons, and living cells. In comparison to antibodies, they are changeable, non-immunogenic, highly sensitive, less poisonous, easy to create, and have a low molecular weight with no fluctuation across preparations. As a result, they're commonly used in biotechnological and medicinal applications.
Factors such as technological breakthroughs and increased R&D activity are expected to boost the demand for aptamers. Because of favorable government efforts and an increasing number of research laboratories, the United States is a market leader in North America. Due to quick technological breakthroughs and substantial investment and funding to assist the development of aptamers, the North American region dominates the industry.
The US market dominated the North America Aptamers Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $123.6 million by 2027. The Canada market is anticipated to grow a CAGR of 20.1% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 19.1% during (2021 - 2027).
Based on Type, the market is segmented into DNA Aptamers, XNA Aptamers and RNA Aptamers. Based on Application, the market is segmented into Therapeutics Development, Research & Development, Diagnostic and Others. Based on Technology, the market is segmented into SELEX and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Aptamers Market is Estimated to reach $392.7 Million by 2027, at a CAGR of 17.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kaneka Corporation, Aptamer Group PLC, SomaLogic, Inc., RayBiotech Life, Inc., Neoventures Biotechnology, Inc., Maravai Lifesciences Holdings, Inc., Aptus Biotech, Base Pair Biotechnologies, Inc., Alpha Diagnostic International, Inc., and Vivonics, Inc.
By Type
By Application
By Technology
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
